Biological agriculture is a process of eco-friendly farming without the use of chemical pesticides and fertilizers. More specifically, biological agriculture can be defined as a production system based on crop rotation and recycling of animal manure, green manure, and crop residues. It involves reasonable use of agricultural machinery and biological control methods. Biological agriculture is an economically and ecologically sustainable agricultural production system that promotes the use of safe products for crop treatment. This is accomplished by minimizing environmentally harmful consequences and using non-renewable natural resources. Agricultural biologicals is a distinct group of products derived from organic matter such as plant extracts and naturally occurring microorganisms, which are employed to increase the crop productivity and improve the crop health.
The global agricultural biologicals market can be segmented on the basis of type and application. Based on the type, the market can be divided into biopesticides, biofertilizers, and biostimulants. Biopesticides are organic substances that control pests by non-toxic mechanism and improve the crop quality. Biofertilizers are organic substances that contain living microorganisms which promote the crop growth. Biostimulants are organic compounds that are applied to plants or soil to improve the crop quality and quantity as well as tolerance to abiotic stresses. The biopesticides segment held a prominent share of the global agricultural biologicals market in 2015 and is expected to continue its dominance during the forecast period. This is due to the increasing use of biopesticides in place of hazardous chemical pesticides used conventionally. Germany and France are expected to be markets witnessing high growth during the forecast period. Based on the application, the global agricultural biologicals market has been segmented into cereals & grains, oilseeds & pulses, and fruits & vegetables. Being the staple crops all over the world, the cereal & grains segment led the market in 2015, and this trend is expected to continue during the forecast period. This is due to the rising demand for cereals and grains caused by the increasing population.
Growth of the global agricultural biologicals market is attributable to the increasing demand for organic products, improving productivity and yield, rising costs of pesticides and fertilizers, and increasing global population. Primary drivers for the market are increasing demand for organic foods, abbreviated chemical hazards, rapid growth in the use of microbial seed treatment products, and easier residue management. The market gets benefitted also by promotions and support by the governments. The growing health consciousness among people has also increased the demand for organic food products, consequently leading to growth of the global agricultural biologicals market.
In terms of region, the global agricultural biologicals market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. In 2015, Europe was the major market for agricultural biologicals. The region was followed by North America, Asia Pacific, and Latin America in the same year. Europe is expected to lead the global agricultural biological market during the forecast period. Italy and Spain hold a significant share of the market in the region. The European market is primarily driven by factors such as improved quality outcomes, increased yield and productivity, increasing demand for organic products, and adoption of modern technology for agriculture. The market in Asia Pacific is likely to experience significant growth during the forecast period, due to needs of the growing population and government initiatives to promote better environment. The agricultural biologicals market in Latin America is also projected to expand at a rapid pace during the forecast period.
Key players operating in the global agricultural biologicals market are The Dow Chemical Company, Syngenta, BASF SE, Bayer AG, Novozymes, and Isagro. Other prominent players include Marrone Bio Innovation Inc., Certis USA LLC, Arysta LifeScience Corporation, and Koppert B.V.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.